The Department of Veterans Affairs awarded a Federal Supply Schedule (FSS) contract to Hospira Worldwide LLC, a subsidiary of Pfizer Inc., for a wide range of pharmaceutical and medical products under the FSS-61 IB schedule. The $230 million multiple-award contract has a period of performance running from October 1, 2014 through June 30, 2024.
Through this FSS contract, Hospira/Pfizer has provided sterile injectable drugs, antibiotics, anesthetics, IV solutions, and other medical supplies to federal agencies including the Department of Veterans Affairs, Department of Health and Human Services, and Department of Defense. Task orders issued under the contract have ranged from $9,000 to $435,000 for firm fixed-price delivery of these pharmaceutical and medical products, without any set-aside designations. The contract supports the medical supply needs of VA healthcare facilities, Indian Health Service medical centers, and other government healthcare programs across the country.
Generated 5/9/24, 9:13 AM